These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies. Chen XH; Zhang C; Zhang X; Gao L; Gao L; Kong PY; Peng XG; Qi DG; Sun AH; Zeng DF; Liu H; Gong Y; Wang QY Biol Blood Marrow Transplant; 2009 Feb; 15(2):266-73. PubMed ID: 19167687 [TBL] [Abstract][Full Text] [Related]
9. HLA-haploidentical blood and bone marrow transplantation with anti-thymocyte globulin: long-term comparison with HLA-identical sibling transplantation. Chen XH; Gao L; Zhang X; Gao L; Zhang C; Kong PY; Liu H; Peng XG; Sun AH; Qi DG; Gong Y; Wang QY Blood Cells Mol Dis; 2009; 43(1):98-104. PubMed ID: 19356956 [TBL] [Abstract][Full Text] [Related]
10. Unrelated mismatched cord blood transplantation in an adult with secondary AML. Lambertengh Deliliers G; Soligo D; Della Volpe A; Bertolini F; Poli F; Romitti L; Tagliaferri E; Ibatici A; Onida F; Annaloro C; Gattinoni L; Sirchia G Bone Marrow Transplant; 1996 Aug; 18(2):469-72. PubMed ID: 8864467 [TBL] [Abstract][Full Text] [Related]
11. [Successful treatment of AML by HLA-compatible sibling umbilical cord blood stem cell transplantation--the first case report in China]. Song Y; Wang G; Wan D Zhonghua Xue Ye Xue Za Zhi; 1999 Aug; 20(8):399-401. PubMed ID: 11721417 [TBL] [Abstract][Full Text] [Related]
12. Successful prevention of acute graft-versus-host disease using low-dose antithymocyte globulin after mismatched, unrelated, hematopoietic stem cell transplantation for acute myelogenous leukemia. Kim HJ; Min WS; Cho BS; Eom KS; Kim YJ; Min CK; Lee S; Cho SG; Jin JY; Lee JW; Kim CC Biol Blood Marrow Transplant; 2009 Jun; 15(6):704-17. PubMed ID: 19450755 [TBL] [Abstract][Full Text] [Related]
13. Meta-analysis of HLA matching and the outcome of unrelated umbilical cord blood transplantation (CBT). Shi-xia X; Xian-hua T; Hai-qin X; Bo F; Hai-qing C; Xiang-Feng T Transpl Immunol; 2009 Sep; 21(4):234-9. PubMed ID: 19481604 [TBL] [Abstract][Full Text] [Related]
14. Impact of AB0-blood group incompatibility on the outcome of recipients of bone marrow transplants from unrelated donors in the Japan Marrow Donor Program. Kimura F; Sato K; Kobayashi S; Ikeda T; Sao H; Okamoto S; Miyamura K; Mori S; Akiyama H; Hirokawa M; Ohto H; Ashida H; Motoyoshi K; Haematologica; 2008 Nov; 93(11):1686-93. PubMed ID: 18835834 [TBL] [Abstract][Full Text] [Related]
15. Resolution of Behçet's disease after HLA-mismatched unrelated cord blood transplantation for myelodysplastic syndrome. Tomonari A; Tojo A; Takahashi T; Iseki T; Ooi J; Takahashi S; Nagamura F; Uchimaru K; Asano S Ann Hematol; 2004 Jul; 83(7):464-6. PubMed ID: 14652696 [TBL] [Abstract][Full Text] [Related]
16. [Successful treatment of agammaglobulinemia by HLA-mismatched unrelated cord blood stem cell transplantation--the first case report]. Wan DM; Liu CF; Wang GJ; Sun H; Sun L; Jiang ZX; Guo WL; Qin L; Liu SJ Zhonghua Xue Ye Xue Za Zhi; 2005 Jul; 26(7):401-3. PubMed ID: 16251019 [TBL] [Abstract][Full Text] [Related]
17. [Unrelated umbilical cord blood transplantation as a treatment for children with malignant leukemia]. Tang XF; Luan Z; Xu SX; Wu NH; Huang YZ; Wang K Zhongguo Dang Dai Er Ke Za Zhi; 2008 Feb; 10(1):5-8. PubMed ID: 18289460 [TBL] [Abstract][Full Text] [Related]